These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 5885907)
1. The function of androgens and fluoride salts in the treatment of multiple myeloma. Gardner FH; Cohen P Trans Am Clin Climatol Assoc; 1966; 77():226-34. PubMed ID: 5885907 [No Abstract] [Full Text] [Related]
3. Ancillary measures in treatment of myeloma. Use of immune serum globulin, fluoride, or androgen. Schilling A; Finkel HE Arch Intern Med; 1975 Jan; 135(1):193-6. PubMed ID: 46143 [TBL] [Abstract][Full Text] [Related]
4. [The effectiveness of sex hormone replacement therapy in male hypogonadism]. Butrova SA; Kogan BS Probl Endokrinol (Mosk); 1971; 17(5):43-7. PubMed ID: 5148296 [No Abstract] [Full Text] [Related]
5. INDUCTION OF SUBACUTE SKELETAL FLUOROSIS IN A CASE OF MULTIPLE MYELOMA. COHEN P; GARDNER FH N Engl J Med; 1964 Nov; 271():1129-33. PubMed ID: 14200047 [No Abstract] [Full Text] [Related]
6. Constitutional delay of growth and development: effects of treatment with androgens. Kaplan JG; Moshang T; Bernstein R; Parks JS; Bongiovanni AM J Pediatr; 1973 Jan; 82(1):38-44. PubMed ID: 4344244 [No Abstract] [Full Text] [Related]
7. Evaluation of growth and of endocrine systems in testosterone-corticosteroid-treated patients with aplastic anemia. Shahidi NT; Crigler JF J Pediatr; 1967 Feb; 70(2):233-42. PubMed ID: 4289449 [No Abstract] [Full Text] [Related]
8. Fluoride therapy for pain in malignant bone disease. Scott WP Radiology; 1968 Mar; 90(3):588-90. PubMed ID: 4966742 [No Abstract] [Full Text] [Related]
9. Androgen therapy in aplastic anaemia: a comparative study of high and low-doses and of 4 different androgens. French Cooperative Group for the Study of Aplastic and Refractory Anemias. Scand J Haematol; 1986 Apr; 36(4):346-52. PubMed ID: 2872720 [TBL] [Abstract][Full Text] [Related]
10. Antifracture efficacy of long-term estrogens for osteoporosis. Gordan GS; Picchi J; Roof BS Trans Assoc Am Physicians; 1973; 86():326-32. PubMed ID: 4363387 [No Abstract] [Full Text] [Related]
11. The mortality of acquired aplastic anemia in children. Li FP; Alter BP; Nathan DG Blood; 1972 Aug; 40(2):153-62. PubMed ID: 5044585 [No Abstract] [Full Text] [Related]
12. Treatment of diseases of the testes affecting growth and development. Schoen EJ Mod Treat; 1968 Jan; 5(1):184-204. PubMed ID: 4297681 [No Abstract] [Full Text] [Related]
13. Fluoride and calcium therapy for myeloma bone lesions. Cohen P JAMA; 1966 Nov; 198(6):583-6. PubMed ID: 5953428 [No Abstract] [Full Text] [Related]
14. Seminal acid phosphatase content in the clinical bioassay of androgens and antiandrogens. Kent JR; Hill M; Huix FJ; Segre EJ Clin Pharmacol Ther; 1972; 13(2):205-11. PubMed ID: 5017374 [No Abstract] [Full Text] [Related]
16. Letter: Management of multiple myeloma. Yazici H N Engl J Med; 1976 Apr; 294(14):787-8. PubMed ID: 768763 [No Abstract] [Full Text] [Related]
17. Calusterone (NSC-88536): a poor substitute for fluoxy-mesterone (NSC-12165) in the treatment of advanced breast cancer. Falkson G; van Dyk JJ; van Eden EB; van der Merwe AM; FALKSON HC Cancer Chemother Rep; 1974; 58(6):939-41. PubMed ID: 4615788 [No Abstract] [Full Text] [Related]
18. Fluoride treatment of bone rarefaction in multiple myeloma and osteoporosis. A review. Cohen P; Nichols GL; Banks HH Clin Orthop Relat Res; 1969; 64():221-49. PubMed ID: 4893445 [No Abstract] [Full Text] [Related]
19. [Fluoride treatment of osteoporosis]. Schulz W Wien Med Wochenschr; 2000; 150(3):42-52. PubMed ID: 10756596 [TBL] [Abstract][Full Text] [Related]
20. [Fluoride and the osteoarticular apparatus. A review of the literature]. D'Antonio A; Colangelo G Ann Stomatol (Roma); 1969 Aug; 18(8):699-710. PubMed ID: 4900470 [No Abstract] [Full Text] [Related] [Next] [New Search]